Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 15/20 | 0.60 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.40 |
| ▸ | GUSB | P08236 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | G6PD | P11413 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4448216 | 0.89 | CYP19A1 (0.61) | CYP19A1CYP1B1MEN1LMNASHBG | |
| SCHEMBL9939642 | 0.88 | CYP19A1 (0.60) | CYP19A1CYP1B1MEN1LMNASHBG | |
| SCHEMBL29561383 | 0.84 | CYP19A1 (0.56) | CYP19A1CYP1B1MEN1LMNASHBG | |
| SCHEMBL5308575 | 0.82 | CYP19A1 (0.60) | CYP19A1 | |
| SCHEMBL30881329 | 0.82 | CYP19A1 (0.57) | CYP19A1CYP1B1MEN1LMNASHBG | |
| SCHEMBL514563 | 0.82 | CYP19A1 (0.54) | CYP19A1CYP1B1MEN1LMNASHBG | |
| SCHEMBL7475337 | 0.81 | CYP19A1 (0.55) | CYP19A1CYP1B1CYP3A4 | |
| SCHEMBL32677703 | 0.80 | CYP19A1 (0.67) | CYP19A1CYP1B1MEN1LMNASHBG | |
| SCHEMBL606825 | 0.80 | CYP19A1 (0.67) | CYP19A1CYP1B1MEN1LMNASHBG | |
| SCHEMBL4885211 | 0.80 | CYP19A1 (0.67) | CYP19A1CYP1B1MEN1LMNASHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1539183-A4 | THERAPEUTIC TREATMENT METHODS | HOLLIS EDEN PHARMACEUTICALS (US) | 2007-04-25 | — | — | EP | claimed |
| EP-1539183-A1 | THERAPEUTIC TREATMENT METHODS | Hollis-Eden Pharmaceuticals Inc. (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004019953-A1 | THERAPEUTIC TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2004-03-11 | — | — | WO | claimed |